(Q39098613)

9 September 2017

title

Nonsteroidal anti-inflammatory drugs diclofenac and celecoxib attenuates Wnt/β-catenin/Tcf signaling pathway in human glioblastoma cells (English)

1 reference

9 September 2017

0 references

1 reference

1 reference

Gangadhara Reddy Sareddy

1

1 reference

9 September 2017

Divya Kesanakurti

2

1 reference

9 September 2017

Puligurtha Bharadhwaja Kirti

3

1 reference

9 September 2017

Phanithi Prakash Babu

4

1 reference

9 September 2017

language of work or name

1 reference

8 September 2013

1 reference

9 September 2017

published in

Neurochemical Research

1 reference

9 September 2017

volume

38

1 reference

9 September 2017

issue

11

1 reference

9 September 2017

page(s)

2313-2322

1 reference

https://scigraph.springernature.com/pub.10.1007/s11064-013-1142-9

9 September 2017

exact match

0 references

cites work

NSAIDs and cancer prevention: targets downstream of COX-2.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Aspirin, NSAIDS, and colon cancer prevention: mechanisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Diclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Celecoxib inhibits β-catenin-dependent survival of the human osteosarcoma MG-63 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

On target? Strategies and progress in the development of therapies for colorectal cancer targeted against WNT signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Effect of nonsteroidal anti-inflammatory drugs on beta-catenin protein levels and catenin-related transcription in human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Effect of aspirin on the Wnt/beta-catenin pathway is mediated via protein phosphatase 2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Targeting the Wnt/β-catenin signaling pathway in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

The way Wnt works: components and mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Genetic alterations and signaling pathways in the evolution of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Increased β-catenin/Tcf signaling in pilocytic astrocytomas: a comparative study to distinguish pilocytic astrocytomas from low-grade diffuse astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Wnt/beta-catenin/Tcf signaling pathway activation in malignant progression of rat gliomas induced by transplacental N-ethyl-N-nitrosourea exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Therapeutic significance of estrogen receptor β agonists in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Mustard NPR1, a mammalian IkappaB homologue inhibits NF-kappaB activation in human GBM cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

HMG CoA reductase inhibitors, NSAIDs and risk of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Long-term anti-inflammatory and antihistamine medication use and adult glioma risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Case-control study of use of nonsteroidal antiinflammatory drugs and glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Initial experience combining cyclooxygenase-2 inhibition with chemoradiation for locally advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1142-9

Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers

21 January 2018

1 reference

12 December 2020

Cyclooxygenase-independent actions of cyclooxygenase inhibitors

1 reference

12 December 2020

Combination celecoxib and temozolomide in C6 rat glioma orthotopic model.

1 reference

12 December 2020

Reduction of beta-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-catenin

1 reference

12 December 2020

10.1007/S11064-013-1142-9

Identifiers

DOI

1 reference

release_4wu4ryck6zb7nfh336pvowlcu4

9 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4wu4ryck6zb7nfh336pvowlcu4

24 November 2022

mapped directly with Wikidata item

1 reference